Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Helms

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Molecular Pharmaceutics|January 14, 2021
Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer CellsOleksandr Zavoiura, Bodo Brunner, Peter Casteels, et al.
Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.
Blood|April 26, 2011
Genetic predictors for stroke in children with sickle cell anemiaJonathan M Flanagan, Denise M Frohlich, Thad A Howard, et al.
The Journal of Pediatrics|February 28, 2002
Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS StudyWinfred C Wang, Ronald W Helms, Henry S Lynn, et al.
Molecular Cancer Therapeutics|September 14, 2019
Utility of the RIG-I Agonist Triphosphate RNA for Melanoma TherapyMike W Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, et al.
Molecular Cancer Therapeutics|June 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma modelCharlotte Marx, Julia Teppert, Laura Marisch, et al.
Oncotarget|February 1, 2018
Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activationZhihu Ding, Chaomei Shi, Lan Jiang, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Molecular Pharmaceutics|January 14, 2021
Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer CellsOleksandr Zavoiura, Bodo Brunner, Peter Casteels, et al.
Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.
Blood|April 26, 2011
Genetic predictors for stroke in children with sickle cell anemiaJonathan M Flanagan, Denise M Frohlich, Thad A Howard, et al.
The Journal of Pediatrics|February 28, 2002
Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS StudyWinfred C Wang, Ronald W Helms, Henry S Lynn, et al.
Molecular Cancer Therapeutics|September 14, 2019
Utility of the RIG-I Agonist Triphosphate RNA for Melanoma TherapyMike W Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, et al.
Molecular Cancer Therapeutics|June 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma modelCharlotte Marx, Julia Teppert, Laura Marisch, et al.
Oncotarget|February 1, 2018
Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activationZhihu Ding, Chaomei Shi, Lan Jiang, et al.
Pageof 9